Company Overview and News

0
NZ shares lift as Synlait rallies on A2 stake lift

2018-08-03 nzherald.co.nz
New Zealand shares gained, led higher by Synlait Milk as A2 lifted its stake in the company while Freightways and Ebos fell.
KTHDY BGR EBOSF THL PPSHY EBOSY SNZ KMD EBO EBO SML KMD

0
Freightways, Sky TV lead NZ shares gain

2018-07-31 nzherald.co.nz
New Zealand shares gained, led higher by Freightways and Sky Network Television as the market remains quiet ahead of earnings season.
CEN ZNRGF KMD COENF SKT ZNZ GNE SYKWF SKC CEN SKKTY FGHRY KMD GEL KTHDY EBOSY FLT ZEL EBO COENY KWIPF EBOSF EVO GNE GTK EBO

9
Dispensing disruption: Are pharmacies ready for digital rivals?

2018-07-06 theage.com.au
When Amazon announced its purchase last week of online pharmacy PillPack, which packages and delivers pre-sorted doses of prescribed drugs direct to consumers’ homes, major US-based pharmacies from CVS Health to Walgreens saw their share prices fall about 10 per cent.
EBOSF RMYHY API RHC EBOSY CVS EBO RMSYF EBO

9
Dispensing disruption: Are pharmacies ready for digital rivals?

2018-07-06 smh.com.au
When Amazon announced its purchase last week of online pharmacy PillPack, which packages and delivers pre-sorted doses of prescribed drugs direct to consumers’ homes, major US-based pharmacies from CVS Health to Walgreens saw their share prices fall about 10 per cent.
EBOSF RMYHY API RHC EBOSY CVS EBO RMSYF EBO

0
ASX lifts for the week despite the looming trade war

2018-07-06 theage.com.au
The Australian sharemarket has ended the week with a fresh 10-1/2-year high on Friday, despite the US going ahead with tariffs that could potentially begin an all-out trade war with China.
DB API EBOSY EBO RSG EBOSF RMGGY RMGGF MS EBO

0
ASX lifts for the week despite the looming trade war

2018-07-06 smh.com.au
The Australian sharemarket has ended the week with a fresh 10-1/2-year high on Friday, despite the US going ahead with tariffs that could potentially begin an all-out trade war with China.
DB API EBOSY EBO RSG EBOSF RMGGY RMGGF MS EBO

0
NZ shares up; Auckland Airport leads gains

2018-07-05 nzherald.co.nz
New Zealand shares rose in light trading, led higher by Auckland International Airport and Westpac Banking Corp, with Heartland Bank and Fletcher Building softening.
AIA FBU WBC FCREY EBOSY WEBNF WBK ACKDF FRCEF EBO AUKNY EBOSF AIA WBC FBU SKLUY SKL EBO

2
Australian shares advance on strength of major banks

2018-07-03 theage.com.au
The Australian sharemarket has recorded only its second advance in the last eight sessions despite a broad retreat of commodity prices overnight.
PILBF RIO DB BLT RIO IAG BEPTF RTPPF GALXF RTNTF MS TWE SML IAUGY PLS TSRYY BHPBF EBOSY EBO BCHEY BPT EBOSF TSRYF GXY IAUGF BHP RIO BBL BHP BHPLF EBO

2
Australian shares advance on strength of major banks

2018-07-03 smh.com.au
The Australian sharemarket has recorded only its second advance in the last eight sessions despite a broad retreat of commodity prices overnight.
PILBF RIO DB BLT RIO IAG BEPTF RTPPF GALXF RTNTF MS TWE SML IAUGY PLS TSRYY BHPBF EBOSY EBO BCHEY BPT EBOSF TSRYF GXY IAUGF BHP RIO BBL BHP BHPLF EBO

0
NZX 50 rises 1.2% to new record on Ebos Group gains

2018-07-03 nzherald.co.nz
New Zealand shares jumped to a record with Ebos Group hitting a fresh high while A2 Milk Co and Synlait Milk gained on news they plan to extend their supply contract.
EBOSF NZTCY SPKKY OHE EBOSY SPK NZTCF EBO FTRRF EBO SML

2
Sigma told to 'lick wounds' after Chemist Warehouse hammering

2018-07-02 theage.com.au
Sigma Healthcare's largest investor says the company should take time to lick its wounds rather than rush into new investments, after the loss of its biggest contract cut it projected earnings in half and sent its share price plunging 40 per cent in a single day.
EBOSF EBOSY EBO EBO

2
Sigma told to 'lick wounds' after Chemist Warehouse hammering

2018-07-02 smh.com.au
Sigma Healthcare's largest investor says the company should take time to lick its wounds rather than rush into new investments, after the loss of its biggest contract cut it projected earnings in half and sent its share price plunging 40 per cent in a single day.
EBOSF EBOSY EBO EBO

2
MARKET WRAP: Ebos deal dominates otherwise subdued sharemarket

2018-07-02 nbr.co.nz
Harbour Asset Management analyst Shane Solly says global markets could remain volatile due to US tariffs.
EBOSF EBOSY GTK EBO EBO

2
Sigma shares plunge on loss of Chemist Warehouse contract

2018-07-02 theage.com.au
Sigma Healthcare's shares have plunged more than 45 per cent to seven-year lows after the pharmacy operator failed to extend a pharmaceutical supply contract with Chemist Warehouse and said it would have to cut costs to survive.
EBOSF EBOSY EBO EBO

2
Sigma shares plunge on loss of Chemist Warehouse contract

2018-07-02 smh.com.au
Sigma Healthcare's shares have plunged more than 45 per cent to seven-year lows after the pharmacy operator failed to extend a pharmaceutical supply contract with Chemist Warehouse and said it would have to cut costs to survive.
EBOSF EBOSY EBO EBO

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...